SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " biotech " 225 found 🔀 AI-powered Shuffle
AB Science cuts three trials in pipeline reset
French biotech AB Science is discontinuing three masitinib trials as it concentrates its clinical resources on an ALS phase 3 programme and the early-stage development of AB8939 in acute myeloid leukaemia.
DGIST secures four projects under the Ministry of Science and ICT’s Group Research Support Program, spanning basic science to cutting-edge deep tech
- DGIST secured one Science Research Center (SRC) project and three Basic Research Laboratory (BRL) projects, taking the lead in addressing national challenges in science and technology - DGIST reaffirms its world-class convergence research capabilities spanning AI, robotics, and advanced biotechnology
Scientists enable DNA synthesis using only temperature instead of chemical reagents
"Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been overturned by a Korean research team. A KAIST research team has developed the ...
Inside the BoF and Clinuvel Community Lunch Exploring the Future of Skin Health
Investors from Goldman Sachs, L Catterton and Bansk Beauty joined leaders from L’Oréal, Harrods, Space NK and Unilever at The Business of Beauty Global Forum to examine how advances in medicine, biotechnology and longevity are redefining the future of skin health.
Inside the BoF and Clinuvel Community Lunch Exploring the Future of Skin Health
Investors from Goldman Sachs, L Catterton and Bansk Beauty joined leaders from L’Oréal, Harrods, Space NK and Unilever at The Business of Beauty Global Forum to examine how advances in medicine, biotechnology and longevity are redefining the future of skin health.
Startups move to Colorado amid concerns state losing its luster for tech companies
A biotech startup and an aerospace startup said their moves to Colorado were based on lifestyle issues and the state’s business climate.
From recombinant DNA to AI: Who gets a say in powerful new science?
Professor Luis Campos studies the history of biology and biotechnology.
Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology
Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology /
Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?
One offers broad stability with lower costs and higher income, while the other chases biotech growth with 89.3% annual returns but steeper volatility.
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up?
Broad healthcare diversification or concentrated biotech growth? Compare cost, risk, and portfolio composition to find your fit.
Xtalks Announces its Life Science Webinar Calendar for July 2026
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns
Compare portfolio diversity, risk profiles, and income potential as you weigh these two leading healthcare ETFs.
Middle School Students Conduct Summer Science Experiments at USU STARS GEAR UP Biotechnology Camp
Utah middle school students from Sanpete County gained hands-on STEM experience during a two-day Biotech camp in June.
Exploring STEM Futures through UConn 4-H’s Biotechnology Club
The Biotechnology Club is intentionally designed to complement classroom learning and prepare Connecticut students to enter the skilled, science-literate wo ...
Wilmington Small Business Coalition: Building Momentum in 2026 by Heather McWhorter
This article was contributed by Lydia Thomas, UNCW CIE Program Manager. North Carolina continues to be one of the best states to start a business and in 2025, Wilmington, North Carolina earned a spot on the GoDaddy list of the top 10 most entrepreneurial cities in the U.S. While many know Wilmington as small beach town with exceptional food, lots of coffee shops, and fun, vibrant summer activities, a closer look reveals a thriving innovation economy. You’ll find startups emerging across industries including software, healthtech, bluetech, and fintech. At the core of this entrepreneurial ecosystem is the Wilmington Small Business Coalition, with small business advocates and entrepreneur support organizations (ESOs) dedicated to helping founders grow, thrive, and succeed. “No Wrong Door” Established in 2016, the Coalition was designed to make it easier for individuals and small businesses to access resources most suited to their particular needs. The Coalition is designed to have a “no wrong door” entryway into the regional startup ecosystem. Whether you are exploring a new idea sketched on the back of a napkin or leading a more established, growth-stage company, Coalition members can help connect you with the programs, funding opportunities, mentors, and resources best suited to your needs. No matter where you are in your entrepreneurial journey, any Coalition organization can help point you in the right direction. Coalition Members and Leadership Coalition members include the UNCW Center for Innovation and Entrepreneurship (UNCW CIE), AARP, Brunswick Community College Small Business Center, Cape Fear Community College Small Business Center, Cape Fear Region SCORE, Genesis Block Foundation, Network for Entrepreneurs in Wilmington (NEW), Small Business & Technology Development Center (SBTDC), Greater Wilmington Chamber of Commerce, YWCA Living the Dream Center for Entrepreneurship, Carolina Community Impact Fund (CCI Fund), Partner Community Capital, 717mkt Office Collaborative, NC Biotech, and Institute NC. In May 2026, the Coalition held its leadership elections, resulting in the selection of a new executive team. The following officers were elected to serve two-year terms: Chair: Lydia Thomas, UNCW CIE Vice Chair: Diane Lantz, CCI Fund Secretary: Aariene Hansley, Genesis Block Foundation Treasurer: Gloria Monroe, SBTDC Vision for the Wilmington Small Business Coalition In 2026, the Wilmington Small Business Coalition continues its work as a collaborative network of organizations. By connecting programs, expertise, and services across partner organizations, entrepreneurs can more easily find the right support at the right time. Rather than operating in silos, the Coalition aims to function as a unified, cohesive system of support for small businesses and entrepreneurs, ensuring that resources and expertise across partner organizations are visible and accessible. Through stronger collaboration and shared pathways, entrepreneurs can move more seamlessly from idea to startup to growth. Looking to dive into the Wilmington entrepreneurial ecosystem? Connect with any of the Coalition partners to get started! Connect with CIE To learn more about CIE and our services, programs, and events, join the CIE newsletter. You can also follow us on social media: Instagram, Facebook, LinkedIn, TikTok, or YouTube. CIE’s website is uncw.edu/cie. Heather McWhorter is the director of the UNCW Center for Innovation and Entrepreneurship (CIE). CIE supports innovation-forward start-ups and helps to build a vibrant innovation economy for all in southeast NC.
Indy economic development leaders visiting Switzerland on trade trip
The trip will involve meetings with leaders in the life sciences, biotechnology and pharmaceuticals, medical technology, digital heath and advanced manufacturing sectors.
Databricks and Nvidia Launch Genesis Workbench for AI Scientists
AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work […]
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined company at closing anticipated to fund...
Investor Clive Meanwell on designing biotechs for population health, and AI's role as a catalyst
Clive Meanwell, chairman of investment firm Population Health Partners, was an AI skeptic until recently. Now, he thinks it's a catalyst.
AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
Edison Scientific and investment firm Population Health Partners are teaming up to leverage AI agents in drug discovery and development.
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
Germany's Merck to buy Bio-Techne for $73 per share
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and healthcare firm said in a statement on Thursday.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
Health Brief: FDA signals reset in drug reviews
Plus: The data behind China’s biotech surge
Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 months
As the biotech world flocks to San Diego today for the BIO International Convention, the Department of Health and Human Services has provided plenty of conversation fodder with the announcement of | As the biotech world flocks to San Diego today for the BIO International Convention, the Department of Health and Human Services has provided plenty of conversation fodder with the announcement of a series of efforts to regain ground on China’s surging early-stage clinical development capabilities.
Bigger, fewer, tougher: the new era of China-US biotech partnerships
China’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls.
Philippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders
The French investor and entrepreneur reveals how he is building biotech and medtech giants to compete with China and the U.S.
Building Scientists in the AI Era
Stevens Institute of Technology’s newly launched AI in Biology and Chemistry Community helps students explore AI’s role in health care, biotech and ed-tech careers.
How a biotech turned a trial failure into an AI model
In this edition of STAT Health Tech: How a biotech startup turned a failed clinical trial into an AI model, and more.
Adaptive plots splitting Pfizer-partnered drug discovery unit from diagnostics business
Adaptive Biotechnologies is planning to separate its drug discovery and diagnostics businesses,
NMSU helps launch biotech game that lets students explore science careers
NMSU and UConn Extension developed a free 4-H biotech game that lets students explore 10 science careers through hands-on tasks.
Heart Health Biotech Kardigan Seeks $373.3 Million in US IPO
Kardigan Inc. is seeking to raise $373.3 million in a US initial public offering to help fund three late-stage drugs that target cardiovascular diseases.
A Newer Approach to Editing Embryos Ignites Debate
Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out diseases or trigger a rush toward enhancement.
California wants to cap business tax credits, alarming life sciences and tech industries
California's life sciences industry, and some lawmakers, urge state leaders to reject budget proposal to permanently limit R&D tax credits.
Human Research, Biotechnology for Advanced Health Fill Station Research Schedule
Wednesday’s science schedule aboard the International Space Station encompassed human research, microbial analysis, and 3D bioprinting to advance health on and off the Earth. The Expedition 74 crew members also worked on spacesuit maintenance and cargo spacecraft duties throughout the day rounding out their shift.
Fulcrum tanks as cancer concerns stymie sickle cell asset, trigger business reorg
Fulcrum Therapeutics’ is down more than 50% Tuesday morning as the biotech discontinues development of its lead asset. Ipsen’s Tazverik, which belongs to the same class, was pulled from the market in March due to the risk of secondary malignancies.
Are Chinese biotech firms an ally or an existential threat?
The question of whether to partner with Chinese firms — or see them as rivals — is tearing biotech apart.
P2 Science Raises $23 Million to Produce Green Chemicals for Beauty, Personal Care Sectors
Biotechnology and green chemistry company P2 Science announced that it has raised $23 million in a new financing round, with proceeds aimed at accelerating its growth in the beauty and personal care ingredients market, and expanding its platform into new markets. Co-founded by Professor Paul Anastas and Dr. Patrick Foley at the Center for Green […]
Ebola, chemical plants and health, hantavirus, common colds, heat and more
As they say, bugs have ears. Public health has had a relentless May. Chemical plant (near) explosions, Ebola, hantavirus, and that's before you even get to the usual suspects: common colds, heat, and ticks. Here’s an attempt to keep you up to speed and, more importantly, what it means for you and your community. But first, an announcement: World Cup The World Cup starts in 15 days (not like anyone is counting down), and we are hanging TVs in the Health Security Operations Center. It’s going to be a gorgeous, chaotic celebration of basically every culture on earth. And it’s going to take a team effort—from communities to individuals, from public health to health care—to keep people healthy. That’s where you come in. If you’re going to the games or live within 30 miles of a stadium, we would love to hear from you. Sign up for a weekly survey here. Thanks to the more than 1,280 people who have already signed up…you will be hearing from us soon!! Global disease “weather report” Hantavirus: Two more cases The global count of cruise ship passengers with hantavirus has now increased to 13 cases (11 confirmed), with three deaths. The two new cases are overseas and among people who were already quarantining: A crew member in the Netherlands. A Spanish national passenger who was quarantining at home tested positive through daily monitoring. They are now in a biocontainment unit. In the U.S., everyone remains negative. There may be more cases, given that the incubation period of hantavirus (the time from exposure to infection) is 45 days. But this week, we will reach a major milestone: the median incubation window is 18 days, and that will pass on May 29. What this means for you: Your risk from this cruise ship outbreak remains essentially nil at this point. Ebola rages on in Central Africa Big thanks to Dr. Craig Spencer, a humanitarian physician who has treated and survived Ebola, for jumping in to provide the YLE community with an update. Craig, take it from here… The combined confirmed and suspected Ebola cases in DRC are now more than 1,000. All signs are pointing to a very long and catastrophic outbreak in Central Africa: This is a vast undercount. We know this because the test positivity rate is hovering around 50%, only 20% of contacts are being traced (and in some areas, no contacts at all), and more cases keep popping up with no known connection. This all points to widespread and undetected community transmission. This is in only a week of detection. Compared to previous outbreaks, the growth is very fast, as the huge West Africa outbreak in 2016 was first detected at 49 cases and rose to 208 cases a month later. It took four months for that outbreak to reach the size of the current one in the DR Congo. The cases are spread out across 16 health zones. There are now multiple epicenters, making containment very difficult. Next door in Uganda, the case count is seven. While this number is low compared to DRC, a concerning development is that two health care workers recently tested positive with uncertain exposure histories. If they weren’t treating known Ebola cases, this means it’s spreading undetected in Uganda as well. On the ground, backlash, including the burning of health centers, has emerged, a pattern seen in nearly every outbreak and rooted in deep community distrust. It often stems from outside actors working in communities without fully understanding or addressing local priorities. Affected populations may recognize the severity of Ebola while still holding other concerns as more pressing, such as where their loved ones are buried. Community trust is essential to an effective response, but difficult to build during an active emergency. It is best established long before a crisis begins. U.S. priorities are made clear, and may backfire. The U.S. Administration has shown that its first priority is keeping Ebola out, with helping end the outbreak in the DRC a secondary concern. That's meant travel restrictions broader than anything we've imposed before — covering travelers from across the region, and reportedly some green card holders and permanent residents as well. For example, just these past two days, news broke that high-risk American travelers will be subject to a mandatory quarantine in Kenya before they are allowed to return. If an American is infected, the U.S. government plans to send them to a hospital it is standing up from scratch in Kenya. (Currently, Americans who were in the area are allowed to return but are diverted to three airports—Houston, Atlanta, and DC—for further screening.) Past administrations have used travel notices and stepped-up screening; this goes much further. At first blush, these strict precautions may sound prudent. But this approach could backfire in three ways: Restrictions this blunt give people every reason to hide where they’ve been and whom they’ve been near — making the people we most need to find harder to track, not easier. They also breed a false sense that this is someone else’s problem. But diseases are humbling. They find the small cracks in even the most impenetrable-seeming defenses. Lives lost. There is no treatment for this Ebola strain, which means survival depends heavily on the quality of the health system. We have that system in the States, but we are choosing not to use it for infected Americans. This is unbelievable and infuriating. (See a deeper dive from me here.) The only real way to lower the risk to Americans — and everyone else — is to end the outbreak in the DRC and across the region. What this means for you: If you have travel plans to this region, it’s time to cancel them. This is a high-risk situation in Central Africa, and CDC released a Level 4 Travel Advisory. There is also great uncertainty if and when the Administration will let you back in. To the general public in the U.S., your risk remains very, very low right now. U.S. disease “weather report” Ticks: past peak season? Good news, especially for people in the Northeast and Midwest: tick numbers continue to decline. Though we are at the peak of the season, this unusually early year is trending favorably. Heat-related illnesses in the North Heat risk is certainly not blanketing the entire country yet, but this week it will be moderate in the Midwest and the Southeast. What this means for you: Be sure to check the CDC HeatRisk tool. A red day isn’t the best day for that soccer game for a kid with asthma, and a stretch of orange days is a great time to check on your elderly neighbor. Common colds surging As far as respiratory viruses go, the only thing really going around right now is the common cold. It is higher this year than last year, but should peak very soon before returning this fall. Spotlight: Chemical plants Over the weekend, YLE California covered the serious situation that unfolded around a chemical plant in Orange County, California. Thankfully, the worst-case scenario (a chemical explosion) was mitigated, but only through luck. The health implications in a densely populated area could have been catastrophic. As the situation was winding down, another chemical explosion struck Washington State. This one was fatal. Health officials say the risk to surrounding residents from chemicals in the air and ground remains low, though the community deserves far greater clarity. Clean air and clean water consistently rank as Americans’ top public health concerns — yet when chemical disasters strike, communities are too often met with reassurances rather than transparency and accountability. Residents near the 2023 East Palestine, Ohio train derailment, for example, are still waiting to understand the long-term impact on their health, with few clear answers. What this means for you: Many are wondering if facilities processing potentially dangerous materials are in their neighborhoods. This interactive map allows you to enter your ZIP code and see all facilities monitored by the EPA, including any violations. Good news Ebola vaccines and treatment for the Bundibugyo species are in development. Two vaccine platforms are being explored, at least one of which may be deployable in as little as 2 months. One vaccine is being developed by Oxford, and the other uses the same biotechnology as the FDA-approved Zaire species of Ebola. (It may provide cross-protection, but it’s unclear at this point.) On the treatment side, two promising monoclonal antibody cocktails are likely to be deployed, though doses are limited and logistical hurdles remain significant challenges. Anni over at The Biotech Tea had a great explainer about the Ebola vaccine gap, if you want to read more. [ The Biotech Tea The Ebola vaccine gap, reading vessel damage, & the Makary exit 🗝️ Paid subscribers get the Biotech Term of the Week at $30/year (~$2.50/month). I try to keep it intentionally accessible, but if cost is ever a barrier, send me a message. A few people asked about expensing your subscription, so I put together a short email template… Read more 6 days ago · 10 likes · Annicka Evans, PhD ](https://www.thebiotechtea.com/p/the-ebola-vaccine-gap-reading-vessel?utm_source=substack&utm_campaign=post_embed&utm_medium=web) Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS), following more than a decade of debate and input from roughly 22,000 clinicians, researchers, and patients worldwide. This is good because the old name was medically misleading, leading to patients without visible cysts being dismissed or overlooked entirely. The WHO estimates that 70% of people with the condition remain undiagnosed. A more accurate name should improve recognition, reduce stigma, and ultimately help the millions of people living with this condition get diagnosed and treated sooner. Poll Loading... Bottom line Public health situations are everywhere right now. Staying healthy takes public health professionals and systems working tirelessly behind the scenes and each of us showing up for our neighbors and communities. Love, YLE Big thanks to Ed Nirenberg for staying on top of the Ebola vaccines, Hannah Totte for all the figures, Dr. Craig Spencer for the Ebola insight, and Dr. Matt Willis for covering the chemical situation in CA. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “Translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Robotics, Science Underway as Cosmonauts Prep for Wednesday Spacewalk
Robotics controllers wrapped up a weekend of swapping scientific hardware packed inside the SpaceX Dragon cargo spacecraft’s trunk for installation on the International Space Station. Meanwhile, the Expedition 74 crew is continuing its biotechnology and botany research while getting ready for a spacewalk scheduled for Wednesday, May 27.
Breeding Possibilities for Better Crops
Driven by a strong work ethic, Caitlin Kestell, a doctoral student in crop science, pursues genome editing and biotechnology to advance crop improvement and inspire young scientists.
A de-extinction company has hatched live chicks from an artificial eggshell
A biotech company that aims to resurrect lost creatures says it has hatched live chicks in an artificial environment
A chemical found in fish could help reinvent your sunscreen
It’s been over 25 years since the FDA approved a new ingredient for sunscreen in the United States. But a molecule called gadusol found in fish and coral reefs is a promising candidate. It absorbs U.V. rays — acting like a built-in sunscreen for fish. But there’s a big hurdle if scientists want to turn gadusol into human sunscreen: They’d need to make a lot of it. A new study out this week in the journal Trends in Biotechnology takes us a big step closer. Their solution? Using the bacteria best known for making your stomach hurt: e. Coli. Interested in more science? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
AI Life Science Firm Metis TechBio Set for HK Debut After IPO
Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs, is set to begin trading in Hong Kong after raising HK$2.1 billion ($270 million) in an initial public offering.
Curis Provides First Quarter 2026 Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule...
How jellyfish bycatch could be valuable collagen source for cosmetics and biotech
Dr Ainara Ballesteros is a Juan de la Cierva postdoctoral researcher at the Institute of Environment and Marine Science Research at the Catholic University of Valencia, where she leads a research group focused on jellyfish biology, aquaculture, and the sustainable use of marine resources. Her work is centered on developing innovative solutions based on marine science, particularly through the study of underused organisms as sources of high-value compounds within circular bioeconomy and zero-waste strategies. She is joined in this work by Raquel Torres, a PhD student at the same institute, who is carrying out her doctoral thesis within this line of research, focused on jellyfish valorization, collaboration with the fishing sector, and the sustainable management of marine resources. They are co-authors on a new Frontiers in Marine Science article which investigated whether jellyfish accidentally caught by small-scale fishers in Spain could be transformed into a valuable resource instead of being treated as waste. The team worked side by side with fishers to better understand their perceptions of jellyfish bycatch, identify which species are most frequently caught, and evaluate whether one of them, Rhizostoma pulmo, could serve as a sustainable source of high-quality collagen.
ORNL names Kate Evans associate lab director for biological, environmental systems science
The Department of Energy’s Oak Ridge National Laboratory has named Katherine (Kate) Evans as associate laboratory director for the Biological and Environmental Systems Science Directorate (BESSD). Evans will lead the directorate as it advances the science and technology needed to strengthen energy security, safeguard infrastructure and accelerate biotechnology innovation.
ORNL names Kate Evans associate lab director for biological, environmental systems science
The Department of Energy’s Oak Ridge National Laboratory has named Katherine (Kate) Evans as associate laboratory director for the Biological and Environmental Systems Science Directorate (BESSD). Evans will lead the directorate as it advances the science and technology needed to strengthen energy security, safeguard infrastructure and accelerate biotechnology innovation.
MARY BRUNKOW
A chance discovery made around 80 years ago paved the way for Mary Brunkow’s painstaking work, which contributed to redefining how the immune system functions. From investigating an obscure gene dismissed as ‘junk’ by other scientists, to choosing to opt out of academia and conduct her research at a biotech startup, Brunkow has embraced the unexpected throughout her career.
Thymus renaissance poised to boost health and longevity
Nature Biotechnology - Evidence linking thymic function with health and longevity is piling up, and a cluster of biotechnology companies is trying to regenerate the thymus directly or recapitulate...
2026 Fellows Advancing Women's Health Research in Africa
Fellows from 11 countries represent a diverse group of researchers, clinicians, biotechnologists, and innovators committed to women's health research in Africa.
One Health Microbiome Center names next doctoral interns for industry program
Two Penn State doctoral students will spend eight weeks in Germany at the headquarters of global biotechnology company QIAGEN. This marks the third year of the program, a partnership between the One Health Microbiome Center and QIAGEN.
Rep. Erica Layon: Don't let politics stifle biotech innovation in Granite State
Forty-five minutes from the world’s largest biotech hub, New Hampshire has a chance to lead a medical revolution. Two bills before the Senate this month would make that happen. Democrats
Lab-Grown Sperm?! Cool Science or Sci-Fi Gone Wild
A biotech startup claims it’s created human sperm in a lab—sparking equal parts excitement, skepticism, and “wait… should we be doing this?”
Canada’s biotech paradox: strong science, weak scaling
Canada produces a steady stream of biotech startups built on credible academic research. Universities and hospital research centers in Toronto, Montreal, and Vancouver generate discoveries that move quickly into company formation. Early-stage activity is not the constraint. The difficulty tends to surface later, when those companies try to grow.
SPONSORED How small businesses help power Huntsville's growth
Huntsville, Ala.'s global reputation for aerospace, biotech and defense often grabs headlines. But the region's continued growth depends just as much on local entrepreneurs — and access to capital that helps them launch, hire and scale.
Offworld Life Science: Research Hardware For A Biotechnology Investigation
configures research hardware inside a portable glovebag for a biotechnology investigation exploring how bacteria affect heart tissue in the microgravity environment.
Crew Studies Biotech on Tuesday to Advance Health and Space Economy
Biotechnology research seeking to advance human health and the space economy packed the science schedule aboard the International Space Station on Tuesday. The Expedition 74 crew members also explored space physics, updated robotics software, and conducted an emergency drill.
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East
NEWCASTLE, England, April 15, 2026--Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a strategic partnership with JH Health Ltd, a Saudi Arabian company focused on medical and health-related technology. The partnership grants JH Health exclusive rights to use and distribute Atelerix’s hydrogel-based cell and tissue preservation solutions in the Middle East, significantl
Pitt Team Shines in National Bioethics Competition
In an annual tournament where students debate ethical issues in medicine, biotechnology and health care, the Pitt team placed second.
Abbott survey finds ‘information overload, confusion and cost’ affecting health choices in US
Too much information, uncertainty and financial worries are hitting Americans when it comes to making important choices for their health. | Too much information, uncertainty and financial worries are hitting Americans when it comes to making important choices for their health.
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update
Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a potential best-in-class/first-in-class Claudin 18.2-directed bispecific antibody for gastric cancer, has shown robust and durable responses with broad CLDN18.2 activity, favorable safety, as well as potential eligibility for FDA’s Accelerated Approval Pathway with potential initiation of a registrationa
Immunic COO highlights the importance of science-led innovation to mark World Health Day
Immunic Inc (NASDAQ:IMUX, FRA:10VA) chief operating officer Jason Tardio talked with Proactive's Stephen Gunnion about the importance of science-led innovation in tackling neurological diseases, particularly multiple sclerosis, on World Health Day 2026. Tardio highlighted that the biotech industry is fundamentally grounded in scientific research and data, noting that “everything we do is rooted in science.” He explained that Immunic is focused on developing innovative therapies designed to improve patient outcomes and address significant unmet medical needs. The discussion centred on multiple sclerosis (MS), a complex neurological disease that continues to present challenges despite decades of progress. Tardio pointed out that while advancements have been made, “the disease is not solved for,” with many patients still experiencing disability progression and requiring safer, more tolerable treatments. He emphasised the urgent need for innovation, particularly in progressive forms of MS where treatment options remain extremely limited. Immunic’s lead asset, vidofludimus calcium, is being developed as a novel approach aimed at addressing the full spectrum of the disease. Tardio also reinforced the broader mission of the healthcare and biotech sectors, stating that the ultimate goal is to help individuals “live a better quality of life” and “a healthier life longer.” Watch the full interview to learn more about Immunic’s approach to advancing MS treatment through science. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Immunic #MultipleSclerosis #BiotechInnovation #Healthcare #MSResearch #DrugDevelopment #ClinicalTrials #Neurology #WorldHealthDay #ScienceDriven #VidofludimusCalcium #PharmaNews #BiotechNews
Biotech layoffs return: Mass. life science firms cut 745 jobs in Q1
Biotech job cuts return: 14 companies cut 745 jobs in Q1
Goldman is betting Nvidia will get a boost from health care as industry builds out AI capabilities
Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
Mantis Biotech is making 'digital twins' of humans to help solve medicine's data availability problem
Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the human body, representing anatomy, physiology and behavior.
Watch Hua Medicine on Earnings, Business Expansion Plans
Chinese biotech firm Hua Medicine sees robust growth in 2026 after reporting a 93% jump in full-year revenue. Speaking exclusively to Bloomberg's "The China Show," Chief Strategy Officer George Lin discusses the outlook for the company’s flagship drug dorzagliatin and plans to expand to additional markets.
Scientists Stunned: Colossal Eggs Discovered 3,500 Meters Beneath an Active Volcano
Beneath an active seafloor volcano off Vancouver Island, researchers have documented a congregation of giant eggs at roughly 3,500 meters, a discovery that reframes how life can flourish under extreme conditions. The eggs belong to the Pacific white skate, an elusive deep‑sea species adapted to cold, crushing pressure and perpetual darkness. What seemed an unlikely nursery is actually a geothermally warmed refuge, where subtle heat helps embryos survive a marathon incubation. The finding links volcanic energy to a quiet engine of biodiversity, turning a hostile landscape into an incubator. A living volcano, a hidden nursery The seamount long assumed dormant now exhales mineral‑rich, shimmering plumes, proof of hydrothermal life at depth. Expedition cameras swept across black basalt and pale bacterial mats, revealing vents that pulse with warmth. That warmth, though modest by human standards, alters the physics of development for cold‑adapted embryos. In a realm where metabolism creeps, even a few degrees can mean faster growth and higher survival. The volcano is not only active; it is ecologically formative, drafting a blueprint for a thriving oasis. Giant eggs and a skate built for the abyss The Pacific white skate, Bathyraja spinosissima, is built for the abyss: broad wings, armored spines, and a life history that trades speed for endurance. Females lay outsized, rectangular “mermaid’s purses,” often 46–50 centimeters long, packed with rich yolk to fuel years of growth. In the frigid deep, embryos can require around four years to hatch, a timeline that magnifies every energetic advantage. The scale is striking—large eggs, large adults, and a textbook case of deep‑sea gigantism. The volcano’s gentle heat may literally shave months or years from the wait. Why heat matters at the bottom of the sea Hydrothermal circulation delivers low‑level warmth without the turbulence that would scatter fragile egg‑cases. Slightly elevated temperatures accelerate enzyme kinetics, nudging development along while keeping embryos within a safe range. Mineral‑laden fluids likely shape local microbiomes, which, in turn, can influence biofilms on egg surfaces. The environment acts like a slow, steady incubator, countering the deep sea’s tyrannies of cold and scarcity. For a species with long maturation and few offspring, every incremental boost compounds across generations. An ecosystem sculpted by fire and water Seafloor volcanoes create steep environmental gradients, stitching together hot vents, cool eddies, and mineral gardens into mosaic habitats. Microbes harvest chemical energy, seeding food webs that support crustaceans, fishes, and skates. Cameras documented egg‑cases nestled among rocky ledges, near communities nourished by vent‑driven chemistry. These islands of productivity behave like deep‑sea oases, sustaining life far beyond the vent orifice’s flickering light. The nursery’s success underscores how geological forces engineer biological opportunity. “Finding a cradle of life tucked beneath a breathing volcano reminds us that the planet’s harshest places can be profoundly generous.” What the discovery could change The nursery reframes conservation priorities in regions where volcanism quietly underwrites reproduction. Protecting hydrothermal corridors could safeguard entire lifecycles, not just charismatic adults spotted during occasional surveys. It also sharpens questions about how climate‑driven shifts in ocean circulation might influence vent activity, temperature fields, and embryo survival. With methodical mapping, time‑series cameras, and environmental DNA, scientists can track whether nurseries remain stable or drift with geologic rhythms. Key implications include: Enhanced understanding of deep‑sea reproduction at hydrothermal sites. New conservation targets centered on geothermal nurseries. Comparative studies with other volcanic regions, from the Galápagos to rift zones. Biotechnological insights from organisms adapted to long, cold development. Better models of how seafloor heat shapes regional biodiversity. Methods behind the revelation Remotely operated vehicles threaded through chimney fields, gathering video, temperatures, and mineral signatures. High‑definition imagery captured the distinctive, horned egg cases, their edges dusted with fine volcanic silt. Geochemical profiles mapped how heat and chemicals disperse, outlining the “thermal lanes” where eggs most cluster. Combined, these datasets reveal a nursery organized by geothermal topography, with egg‑cases concentrated in pockets of gentle, sustained warmth. A fragile boon in a changing ocean Deep‑sea environments feel remote, yet they intersect with global pressures: mining proposals, cable routes, and shifting oxygen levels. The nursery’s resilience hinges on stable heat flow, intact substrates, and minimal disturbance from noise or sediment. Safeguarding such places is not just about protecting novelty; it preserves a slow, ancient strategy that lets large, long‑lived animals endure in the coldest reaches of the Pacific. Where geology and biology meet, the planet’s deep time still writes living stories. This volcano‑warmed nursery adds a vital chapter to that story, revealing how subtle thermal gifts can tip the scales toward life in the abyss. With each dive, researchers trace the contours of an unseen world, where fire feeds water, and water—against all odds—feeds the future.
Beauty Is A $667 Billion Business And Venture Capital Is Finally Paying Attention
As Cosmoprof Worldwide Bologna wraps its 57th edition this week, AI, biotech, and venture capital are converging on a sector that has long outpaced the attention it receives from institutional investors.
San Antonio eyes ‘City of Science’ future as bioscience sector looks to scale
San Antonio must boost bioscience marketing, investment and workforce to compete with biotech hubs like Dallas and Houston, leaders say.
Roseman University launches life science incubator to promote discoveries
Roseman University is launching a new life science incubator to support the growth of the biotechnology sector in Southern Nevada.
How to Turn a Chicken Egg Into a Drug Factory
A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.
Biotech Company Tivic Health Aims to Advance Immunotherapy Research Programs
Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding biologics development and manufacturing capabilities.
Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research
/PRNewswire/ -- Stealth BioTherapeutics (the "Company"), a commercial-stage biotechnology company focused on the discovery, development, and commercialization...
Couple left biotech jobs to run a farm, how they keep marriage strong
Working together — in corporate jobs and with our own business — has taught us key strategies to help both our careers and marriage thrive.
Seattle’s biotech scene is world-class — Life Science Washington is teaching it how to brag
Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.
Curis Provides Fourth Quarter 2025 Business Update
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business update and financial results for the quarter ended December 31, 2025.
Curis Provides Fourth Quarter 2025 Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule...
A biotech turns to Apple Watch to study its Parkinson's drug
In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more
SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment
RANCHO CORDOVA, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term growth strategy across three business units: small molecule, peptides, and viral vectors. SK pharmteco is sharpening its strategy to provide pharmaceutical and biotechnology partners with the financial strength, technical rigor, and operational infrastructure needed for long-term
DOE Announces $293 Million Genesis Mission Funding for Quantum Science and AI-Driven Research
DOE announces $293M Genesis Mission funding for AI-driven research in quantum information science, advanced manufacturing, biotechnology, and nuclear energy.
New Grant to Grow Interdisciplinary Biochemistry Master’s Program
Dontae Mosley wasn’t sure graduate school was within his reach due to financial constraints, but thanks to the Interdisciplinary Biochemistry Master’s Program, he was able to pursue his master’s degree and launch his career in the biotech industry. Now, more biochemistry graduate students will have the same opportunity through a new grant from the National Science Foundation.
More Than Just Metadata: Engineering a Healthier Future
How a current Gonzaga M.S. in Data Science student plans to use her degree in the biomedical or biotechnology industry to help improve well-being.
Biomolecular profiling for noninvasive health monitoring
Nature Biotechnology - Kim et al. present mass spectrometry and wearable sensor technology as complementary approaches that, when integrated, can co-evolve to open new possibilities for noninvasive...
Red states hit hardest by reduced NIH funding
Epstein's "great friend" returns to biotech, sex differences in suicide, and other health news from Morning Rounds
Human Brain Cells Run New Data Centers in Singapore, Melbourne
Biotech startup Cortical Labs is working on two small data centers run by human brain cells, putting lab-grown neurons onto silicon in an experiment that could one day challenge chips from the likes of Nvidia Corp.
Exclusive | FDA’s Controversial Vaccines Chief Will Leave the Agency
Dr. Vinay Prasad will depart in April, after a year leading the division that approves vaccines and biotech drugs.
Community science inspires curiosity, inclusion, and discovery
The Yale School of Public Health collaborated with Celentano Biotech, Health and Medical Magnet School, and New Haven Public Schools, to create The Tree of
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to provide more effective and durable treatment than the current standard of care for patients with wet AMD, DME and RVO Visara, a NovaBridge Majority-Owned Subsidiary, Holds Global Rights to VIS-101 Outside of Greater China and Certain Asian Territories ROCKVILLE, Md., March 03, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform co
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 in CGD; plan to submit BLA following final alignment -- -- Prime Medicine reported cash, cash equivalents, investments, and restricted cash of $191M providing cash runway into 2027 -- CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company
Conexeu Sciences Appoints Jean-Romain (JR) Falconnet as Head of Business Development & Licensing
Reno, Nevada--(Newsfile Corp. - March 2, 2026) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a biotechnology innovator redefining regenerative medicine through a next-generation extracellular matrix platform, is pleased to announce Jean-Romain (JR) Falconnet as Head of Business Development & Licensing.In his role at Conexeu, JR will lead business development, licensing strategy, and strategic partnerships—supporting the company's growth roadmap and expanding opportunities to bring...
Codex Labs to Attend Health.tech Global Summit to Advance Root Cause Dermatology Innovation
BASEL, Switzerland - February 24, 2026 - Codex Labs, a biotech skincare company focused on integrative dermatology and
Agentic AI and the rise of in silico team science in biomedical research
Nature Biotechnology - This study examines the emerging use of agentic artificial intelligence (AI) in biomedical research, highlighting the challenges and opportunities that may inform the design...
NJ technical high schools foster innovative science research
Bergen County and Passaic County technical schools in NJ empower students with advanced science research and biotechnology programs.
Got $10,000? Axsome Therapeutics Could Be a Mental‑Health Moonshot by 2036
The biotech is slowly rising in prominence.
Bridging science and society in the emerging bioeconomy
A new MIT course, STS.059 (The Bioeconomy and Society), explores the social and political factors at work in the biology, biotech, and biological engineering sectors.
Scientists test “smart” nanotech to target cancer tumors with more precision
UC Davis scientists are researching “smart” nanoparticles that anchor to tumors and enable on‑demand delivery of cancer‑fighting therapies, boosting precision while protecting healthy tissue.
Building biopharma: The communities behind the science
Editor’s note: This is the first of a twice-monthly series that will highlight the vibrant communities that make up the biopharma industry. | What began as a small summit of women biotech CEOs five years ago has grown into a 350-member force gaining momentum, even as political headwinds force others to retreat.
Noubar Afeyan And Sally Kornbluth Talk MIT, Science
Davos MIT leaders urge defending scientific method; AI enables polyintelligence, biotech gains, and education.